Maternal Asthma, Preterm Birth, and Risk of Bronchopulmonary Dysplasia

Journal of Pediatrics

Volumn 167, Issue 4, 2015, Pages 875-880.e1

  Gage, Susan ^a   Kan, Peiyi ^a   Lee, Henry C ^a,b   Gould, Jeffrey B ^a,b,c   Stevenson, David K ^a   Shaw, Gary M ^a   O'Brodovich, Hugh M ^a  

^a STANFORD UNIVERSITY   (United States)

^b California Perinatal Quality Care Collaborative   (United States)

^c California Office of Statewide Health Planning and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; ARTICLE; ASTHMA; CALIFORNIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HIGH RISK INFANT; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL ASTHMA; MATERNAL TREATMENT; MIDDLE AGED; ODDS RATIO; POPULATION; PREMATURE LABOR; PREMATURITY; PRENATAL PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; YOUNG ADULT; ADOLESCENT; BIRTH WEIGHT; BODY MASS; BRONCHOPULMONARY DYSPLASIA; ENVIRONMENTAL EXPOSURE; HOSPITAL DISCHARGE; MATERNAL AGE; MOTHER; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; UNITED STATES;

ADOLESCENT; ADULT; ASTHMA; BIRTH WEIGHT; BODY MASS INDEX; BRONCHOPULMONARY DYSPLASIA; CALIFORNIA; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MATERNAL AGE; MATERNAL EXPOSURE; MIDDLE AGED; MOTHERS; ODDS RATIO; PATIENT DISCHARGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RISK FACTORS; STEROIDS; YOUNG ADULT;

EID: 84938635522     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.06.048     Document Type: Article

References (27)

1. 1 Kwon, H.L., Belanger, K., Bracken, M.B., Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 13 (2003), 317–324.
2. 2 Murphy, V.E., Namazy, J.A., Powell, H., Schatz, M., Chambers, C., Attia, J., et al. A meta-analysis of adverse perinatal outcomes in women with asthma. Br J Obstet Gynecol 118 (2011), 1314–1323.
3. 3 Mendola, P., Laughon, S.K., Mannisto, T.I., Leishear, K., Reddy, U.M., Chen, Z., et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol 208 (2013), 127.e1–127.e8.
4. 4 Martin, J.A., Kung, H.C., Mathews, T.J., Hoyert, D.L., Strobino, D.M., Guyer, B., et al. Annual summary of vital statistics: 2006. Pediatrics 121 (2008), 788–801.
5. 5 Nickerson, B.G., Taussig, L.M., Family history of asthma in infants with bronchopulmonary dysplasia. Pediatrics 65 (1980), 1140–1144.
6. 6 Hagan, R., Minutillo, C., French, N., Reese, A., Landau, L., LeSouef, P., Neonatal chronic lung disease, oxygen dependency, and a family history of asthma. Pediatr Pulmonol 20 (1995), 277–283.
7. 7 Voltolini, C., Torricelli, M., Conti, N., Vellucci, F.L., Severi, F.M., Petraglia, F., Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Reprod Sci 20 (2013), 1274–1292.
8. 8 Kramer, M.S., Coates, A.L., Michoud, M.C., Dagenais, S., Moshonas, D., Davis, G.M., et al. Maternal asthma and idiopathic preterm labor. Am J Epidemiol 142 (1995), 1078–1088.
9. 9 Bertrand, J.M., Riley, S.P., Popkin, J., Coates, A.L., The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 312 (1985), 742–745.
10. 10 Jobe, A.H., Bancalari, E., Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001), 1723–1729.
11. 11 Berg, C.J., Mackay, A.P., Qin, C., Callaghan, W.M., Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol 113 (2009), 1075–1081.
12. 12 Fridman, M., Korst, L.M., Chow, J., Lawton, E., Mitchell, C., Gregory, K.D., Trends in maternal morbidity before and during pregnancy in California. Am J Public Health 104:Suppl 1 (2014), S49–S57.
13. 13 Murphy, V.E., Wang, G., Namazy, J.A., Powell, H., Gibson, P.G., Chambers, C., et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. Br J Obstet Gynecol 120 (2013), 812–822.
14. 14 Mendola, P., Mannisto, T.I., Leishear, K., Reddy, U.M., Chen, Z., Laughon, S.K., Neonatal health of infants born to mothers with asthma. J Allergy Clin Immunol 133 (2014), 85–90.e1-4.
15. 15 Litonjua, A.A., Carey, V.J., Burge, H.A., Weiss, S.T., Gold, D.R., Parental history and the risk for childhood asthma. Does mother confer more risk than father?. Am J Respir Crit Care Med 158 (1998), 176–181.
16. 16 Northway, W.H. Jr., Rosan, R.C., Porter, D.Y., Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 276 (1967), 357–368.
17. 17 Van Marter, L.J., Allred, E.N., Leviton, A., Pagano, M., Parad, R., Moore, M., et al. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr 138 (2001), 198–204.
18. 18 Egreteau, L., Pauchard, J.Y., Semama, D.S., Matis, J., Liska, A., Romeo, B., et al. Chronic oxygen dependency in infants born at less than 32 weeks' gestation: incidence and risk factors. Pediatrics, 108, 2001, e26.
19. 19 Wells, L.R., Papile, L.A., Gardner, M.O., Hartenberger, C.R., Merker, L., Impact of antenatal corticosteroid therapy in very low birth weight infants on chronic lung disease and other morbidities of prematurity. J Perinatol 19 (1999), 578–581.
20. 20 Marshall, D.D., Kotelchuck, M., Young, T.E., Bose, C.L., Kruyer, L., O'Shea, T.M., North Carolina Neonatologists Association. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 104 (1999), 1345–1350.
21. 21 Van Marter, L.J., Leviton, A., Kuban, K.C., Pagano, M., Allred, E.N., Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics 86 (1990), 331–336.
22. 22 Doyle, L.W., Kitchen, W.H., Ford, G.W., Rickards, A.L., Lissenden, J.V., Ryan, M.M., Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr 108 (1986), 287–292.
23. 23 Gagliardi, L., Bellu, R., Rusconi, F., Merazzi, D., Mosca, F., Antenatal steroids and risk of bronchopulmonary dysplasia: a lack of effect or a case of over-adjustment?. Paediatr Perinat Epidemiol 21 (2007), 347–353.
24. 24 Kunzmann, S., Collins, J.J., Kuypers, E., Kramer, B.W., Thrown off balance: the effect of antenatal inflammation on the developing lung and immune system. Am J Obstet Gynecol 208 (2013), 429–437.
25. 25 Kramer, B.W., Kramer, S., Ikegami, M., Jobe, A.H., Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 283 (2002), L452–L459.
26. 26 Kramer, B.W., Kallapur, S., Newnham, J., Jobe, A.H., Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14 (2009), 2–7.
27. 27 Benjamin, J.T., Carver, B.J., Plosa, E.J., Yamamoto, Y., Miller, J.D., Liu, J.H., et al. NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression. J Immunol 185 (2010), 4896–4903.